MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Quantifiable changes in cortical visual processing in patients with Parkinson’s disease but no cognitive impairment

R.S. Weil, B. Bahrami, D.S. Schwarzkopf, H. Burn, J.D. Warren, H.R. Morris (London, United Kingdom)

Meeting: 2016 International Congress

Abstract Number: 1418

Keywords: Cognitive dysfunction, Visuospatial deficits

Session Information

Date: Wednesday, June 22, 2016

Session Title: Cognition and Psychiatry

Session Time: 12:00pm-1:30pm

Objective: To demonstrate quantifiable differences in cortical visual processing in patients with Parkinson’s disease with no evidence of dementia, as compared to controls.

Background: Visual symptoms are frequently reported in Parkinson’s disease. Previous reports have focussed on ophthalmic changes such as visual acuity, contrast sensitivity and colour deficits, rather than higher visual perceptual changes. Measurable evidence of cortical visual loss will be important as a behavioural marker of cortical involvement in Parkinson’s disease, and may precede overt cognitive disability.

Methods: Cat and dog stimuli of varying degrees of skewness were presented to patients with idiopathic Parkinson’s disease, defined by QSBB criteria (n=7) and healthy age-matched controls (n=7). Average disease duration was 5 years (± 2.9 years), with a mean L-dopa equivalent dose of 458 mg (± 203 mg). Stimuli were generated using an online database of cats and dogs that were cropped and converted to grayscale. Fourier transforms of each image were computed producing magnitude and phase matrices. For each trial, the phase matrix of a cat or dog image was skewed along the x-axis by a variable amount of skew, combined with a proportion of white noise and then recombined with the average magnitude matrix of the entire series. The resulting images had identical spatial frequency with varying degrees of skew. On each trial participants were asked to decide if the image they had seen was a cat or a dog by pressing one of two keys. Psychophysical curves of relative skew against correctness were generated, to determine the threshold for detection of cat or dog. Neuropsychological, visual and motor assessments were also completed.

Results: Non-demented patients with Parkinson’s disease showed significantly impaired ability to identify skewed images compared with healthy controls. Threshold for identifying skewed images was 57.4 degrees skew (±10.3 degrees) in patients with Parkinson’s disease, compared with 68.2 degrees (± 1.68 degrees) in heathy controls, t(12)=2.724, p=0.018. There was no difference between the groups in visual acuity or in neuropsychological performance.

Conclusions: We present evidence for quantifiable differences in higher visual processing in patients with Parkinson’s disease without dementia. This measure may be used as a marker of cortical disease in Parkinson’s disease.

To cite this abstract in AMA style:

R.S. Weil, B. Bahrami, D.S. Schwarzkopf, H. Burn, J.D. Warren, H.R. Morris. Quantifiable changes in cortical visual processing in patients with Parkinson’s disease but no cognitive impairment [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/quantifiable-changes-in-cortical-visual-processing-in-patients-with-parkinsons-disease-but-no-cognitive-impairment/. Accessed May 12, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/quantifiable-changes-in-cortical-visual-processing-in-patients-with-parkinsons-disease-but-no-cognitive-impairment/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley